Recordati SpA (MIL:REC)
€ 51.1 0.05 (0.1%) Market Cap: 10.55 Bil Enterprise Value: 11.87 Bil PE Ratio: 25.26 PB Ratio: 5.61 GF Score: 95/100

Recordati Industria Chimica e Farmaceutica SpA to Discuss About Acquisition of EUSA Pharma (UK) Ltd Call Transcript

Dec 03, 2021 / 12:30PM GMT
Release Date Price: €53.44 (-0.52%)
Operator

Good afternoon. This is the chorus call conference operator. Welcome, and thank you for joining the Recordati, the acquirer of Eusa Pharma conference call. (Operator Instructions) At this time, I would like to turn the conference over to Mr. Federica De Medici, Investor Relations and Corporate Communications. Please go ahead, madam.

Federica De Medici
Recordati Industria Chimica e Farmaceutica S.p.A. - Director of IR & Corporate Communications

Thank you, Jodie. Good afternoon or good morning, everyone, and thank you for attending the conference call today. I'm pleased to be here with our new Chairman, Andrea Recordati; our new CEO, Rob Koremans; and Luigi La Corte, our CFO; and Gabriele Finzi, Head of Business Development; and Corrado Castellucci, Head of Recordati Rare Disease.

With a short presentation, we will provide more color on the strategic rationale and present the transaction in more detail. As to slide is available on our website under the Investors section. At the end of the presentation, we will answer any questions you may have. I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot